Tuesday, May 26, 2026

Can Samjin Pharm Overcome Generic Drug Price Cuts With AI-Driven Drug Development?

Samjin Pharm shifts focus to R&D, moving away from generics to innovative drug development, amid government price cuts.

Tesla’s Market Cap Dips Below $1.1 Trillion After Setback from Chinese Rival BYD

Tesla's stock fell over 6% after BYD's robotaxi announcement, dropping its market cap to $1.057 trillion and 8th place in rankings.

North Korea Uses Youth Congress to Reinforce Construction and Ideological Campaigns

Kim Jong Un emphasizes youth's role in socialist construction at the 11th Congress of the Socialist Patriotic Youth League.

Tag: Truxima

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Truxima: How the First Korean Biosimilar Achieved 35.8% Market Share in the U.S.!

Celltrion’s Truxima becomes South Korea's first biosimilar to lead U.S. prescription market, boosted by tariff exemptions and strong growth.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.